Connection

Laure Gossec to Tumor Necrosis Factor-alpha

Back to Details
This is a "connection" page, showing publications Laure Gossec has written about Tumor Necrosis Factor-alpha.
Laure Gossec
Connection Strength
0.614
Tumor Necrosis Factor-alpha
  1. Primary inefficacy of TNF inhibitors in patients with axial spondyloarthritis: a long-term follow-up of 25 patients. Rheumatology (Oxford). 2017 06 01; 56(6):896-900.
    View in: PubMed
    Score: 0.323
  2. Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study. Ann Rheum Dis. 2018 04; 77(4):533-540.
    View in: PubMed
    Score: 0.084
  3. Minimal Disease Activity as a Treatment Target in Psoriatic Arthritis: A Review of the Literature. J Rheumatol. 2018 01; 45(1):6-13.
    View in: PubMed
    Score: 0.083
  4. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017 Jun; 76(6):960-977.
    View in: PubMed
    Score: 0.079
  5. Acute anterior uveitis in spondyloarthritis: a monocentric study of 301 patients. Clin Exp Rheumatol. 2019 Jan-Feb; 37(1):26-31.
    View in: PubMed
    Score: 0.022
  6. Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications. Ann Rheum Dis. 2018 12; 77(12):1835-1836.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.